📌 Key Takeaways
- Topic: Silicon Dioxide CAS 7631-86-9: Identification, Properties and Regulatory Information
- Keywords: silicosis
- Published: 2026-11-20 02:56:40
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Silica Tapped Density: Definition, Measurement and Typical Values
- Silica Surface Area Explained: Typical BET Values by Type and Why It Matters
- How to Choose a Silica Supplier: Key Criteria, Certifications and Red Flags
- 108. Vialpando M., Albertini B., Passerini N., Heyden Y.V., Rombaut P., Martens J.A., Mooter G.V.D. Agglomeration of mesoporous silica by melt and steam granulation: Part II: Screening of steam granulation process variables using a factorial design. J. Pharm. Sci. 2013;102:3978-3986. doi: 10.1002/jps.23699. [ DOI ] [ PubMed ] [ Google Scholar ]
- Fused Silica CAS 60676-86-0: Identification, Properties and Safety Data
- Silica as a Flow Agent: How It Improves Powder Flowability
- 31. Ismail A., Sial N., Rehman R., Abid S., Ismail M.S. Survival, expansion, behavior, hematology and serum biochemistry of mice under different concentrations of orally administered amorphous silica nanoparticle. Toxicol. Rep. 2023;10:659-668. doi: 10.1016/j.toxrep.2023.05.006. [ DOI ] [ PMC free piece ] [ PubMed ] [ Google Scholar ]
What Is Quartz Powder? Production, Particle Sizes, Purity Grades and Uses
What is silica (SiO₂)?
quartz sand shortage 40. Szewczyk A., Prokopowicz M. Mesoporous silica pellets - A promising oral drug delivery system? J. Drug Deliv. Sci. Technol. 2020;56:101491. doi: 10.1016/j.jddst.2019.101491. [ DOI ] [ Google Scholar ]
What is the difference between fumed silica and precipitated silica?
silica vs silicone
What drives silica raw material prices?
silica molar mass MSNs are also appropriate for pulmonary drug delivery. Inhalation is an attractive route of administration since the application is non-invasive and patient-friendly [ 18 ]. However, the rapid mucociliary clearance and the mucus hurdle complicate the intake of the API and are obstacles to be overcome [ 18, 25 ]. The mesoporous drug delivery systems may be really helpful in the treatment of lung diseases, as they can passively accumulate in the alveoli [ 25, 56, 72 ]. The passive accumulation is due to their small size, while the sizable surface area, high vascularity, and vascular permeability of the lungs enhance the process [ 56 ]. Furthermore, targeted treatment of tumors or inflamed cells can also be implemented with the functionalization of their surface [ 56, 72 ]. MSNs are typically delivered to the lungs in powder form with dry powder inhalers or suspended in liquid droplets with a nebulizer [ 56 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.